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SHORT REPORT
The adaptor proteins HAP1a and GRIP1 collaborate to activate
the kinesin-1 isoform KIF5C
Alison E. Twelvetrees1,*, Flavie Lesept2, Erika L. F. Holzbaur3 and Josef T. Kittler2,*
ABSTRACT
Binding of motor proteins to cellular cargoes is regulated by adaptor
proteins. HAP1 and GRIP1 are kinesin-1 adaptors that have been
implicated individually in the transport of vesicular cargoes in the
dendrites of neurons. We find that HAP1a and GRIP1 form a protein
complex in the brain, and co-operate to activate the kinesin-1 subunit
KIF5C in vitro. Based upon this co-operative activation of kinesin-1,
we propose a modification to the kinesin activation model that
incorporates stabilisation of the central hinge region known to be
critical to autoinhibition of kinesin-1.
KEY WORDS: Kinesin, Molecular motor, Microtubule transport,
Autoinhibition, Adaptor proteins
INTRODUCTION
Motor proteins perform the mechanical work of cellular transport
systems, which are key components of how cells function andmodify
their behaviour.Many advances have beenmade in understanding the
chemomechanical mechanisms of force generation by motor proteins
(Carter et al., 2016; Hancock, 2016), but critical questions remain
about how motors work within cells.
Kinesins are microtubule motors that move towards the plus ends
of microtubules. The archetypal kinesin, kinesin-1, is formed of two
heavy chains (KIF5A–KIF5C) and two light chains (KLC1–KLC4),
with no apparent preference of heavy chains for particular light
chains. Significant evidence states that kinesin-1, when not bound to
cargo, exists in a folded autoinhibited conformation (Coy et al.,
1999; Friedman and Vale, 1999; Stock et al., 1999). Autoinhibition
is mediated by direct interactions between the head and tail of the
KIF5 (Coy et al., 1999; Kaan et al., 2011) and a central hinge that
allows folding (Friedman and Vale, 1999). KLCs also contribute to
both the inhibition of the motor activity of the kinesin (Blasius et al.,
2007; Verhey et al., 1998) and the activation of the motor by cargo
through release of KLC autoinhibition (Yip et al., 2016). In order to
activate kinesin, current models suggest that the head–tail KIF5
interaction must be overcome (Kaan et al., 2011), the KLC block
must be removed (Blasius et al., 2007; Verhey et al., 1998; Yip et al.,
2016), and adaptor proteins must bind to the ‘cargo-binding domain’
(CBD) of KIF5 (Blasius et al., 2007; Cho et al., 2009). Many
proteins that bind to the KIF5 CBD have been identified for specific
cellular cargoes (see Seeger and Rice, 2013 for a summary). Adaptor
protein specificity underlies the ability of a small number of motor
proteins to transport many unique cargoes. However, direct
activation of KIF5 by adaptor proteins has only been characterised
in a very few cases (Blasius et al., 2007; Cho et al., 2009; Sun et al.,
2011), leaving many questions about how these findings relate to
other structurally diverse, multi-component transport complexes.
Two kinesin adaptor proteins critical for neuronal function are
glutamate receptor interacting protein 1 (GRIP1) and huntingtin-
associated protein 1 (HAP1). GRIP1 was identified as an adaptor
linking excitatory α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid receptors (AMPARs) to KIF5 for their delivery to excitatory
synapses (Setou et al., 2002). It has subsequently been shown to be
important for the trafficking of the transmembrane proteins EphB
receptors (Hoogenraad et al., 2005) and N-cadherin (Heisler et al.,
2014) in dendrites. We have shown previously that HAP1 is an
adaptor between inhibitory γ-amino-butyric acid type A receptors
(GABAARs) and KIF5 necessary for the recycling of receptors back
to the surface of dendrites (Twelvetrees et al., 2010). In addition,
HAP1 is involved in trafficking other neuronal transmembrane
proteins, including: the amyloid precursor protein (McGuire et al.,
2006; Yang et al., 2012), the neurotrophin receptors TrkA, TrkB and
p75NTR (also known as NTRK1, NTRK2 and NGFR, respectively)
(Lim et al., 2017; Rong et al., 2006), and epidermal growth factor
receptors (Li et al., 2003). HAP1 is also essential for the trafficking
of BDNF at several stages of its life cycle (Gauthier et al., 2004; Lim
et al., 2017; Wu et al., 2010; Yang et al., 2011).
Critically, however, there is currently no direct evidence that
either GRIP1 or HAP1 can independently activate kinesin-1 motors
to facilitate transport. Furthermore, despite overlapping roles in
linking cargo to kinesins for dendritic neuronal transport, the
interplay between GRIP1 and HAP1 has not been studied. Here, we
report that GRIP1 and HAP1 form an endogenous kinesin-
activating complex by binding distinct sites on the KIF5C
polypeptide. Using in vitro studies, we demonstrate that HAP1
and GRIP1 work together to activate kinesin. Subsequently, we
propose that kinesin activation may include stabilisation of the
hinge region to prevent folding of KIF5.
RESULTS AND DISCUSSION
GRIP1 and HAP1a form a complex endogenously
There are two isoforms of HAP1 in rodents, HAP1a and HAP1b,
which are identical over the first 578 residues with differing C-terminal
‘tail’ sequences (Fig. 1A,B). HAP1a, but not HAP1b, has a potential
C-terminal type I PDZ domain ligand motif that could bind the PDZ
domains of GRIP1 (Ye et al., 2000). GRIP1 undergoes alternative
splicing at the N-terminus to generate GRIP1a and GRIP1b. To
investigate the possibility of a protein–protein interaction betweenReceived 5 February 2018; Accepted 19 November 2019
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GRIP1 and HAP1, we performed immunofluorescence screening in
co-transfected COS cells (Fig. 1C–F). HAP1a and GRIP1a both form
puncta when expressed in cell lines (see Fig. 2A for singly transfected
cells). Puncta are likely related to an endogenous non-membrane-
bound organelle formed by HAP1; within the hypothalamus, HAP1 is
highly expressed (Chan et al., 2002; Li et al., 2003; Sheng et al., 2006)
and associated with non-membrane-bound cytoplasmic bodies (Li
et al., 1998; Shinoda et al., 1992, 1993; Xiang et al., 2017) that
sequester several key proteins in culture (Prigge and Schmidt, 2007;
Rong et al., 2007; Sheng et al., 2008; Takeshita et al., 2011, 2006).
When co-expressed in the same cells, GRIP1a and HAP1a are
recruited to the same intracellular compartment (Fig. 1C,D). In
contrast, HAP1b has a diffuse cytosolic distribution and does not
overlap with GRIP1a (Fig. 1E,F). As opposed to full-length GRIP1a,
PDZ domains 4–6 of GRIP1 (GRIP1-PDZ456) have a diffuse
cytosolic distribution when expressed in COS cells, but are recruited to
puncta when co-expressed with HAP1a (Fig. S1).
In co-immunoprecipitations (co-IPs) from COS cells co-transfected
with GFP–GRIP1a and HA-tagged HAP1a or HAP1b (HA–HAP1a or
HA–HAP1b), anti-GFP could co-IP HAP1a, but not HAP1b (Fig. 1G).
This confirmed that the interaction is mediated by the 19 amino acids of
the HAP1a tail. Finally, in order to establish whether GRIP1 and HAP1
form an endogenous complex, we performed co-IPs from rat
brain homogenate. A co-IP performed using antibodies for HAP1
that we have previously shown readily co-immunoprecipitate KIF5
(Twelvetrees et al., 2010) also co-immunoprecipitatedGRIP1 (Fig. 1H).
HAP1a but not GRIP1 is trafficked by KIF5C to the cell
periphery
Having observed co-recruitment by immunofluorescence in COS cells
overexpressing GRIP1 and HAP1a, we used immunofluorescence to
compare HAP1 and GRIP1 interactions with KIF5 isoforms.
We demonstrated previously that HAP1a and KIF5 proteins
interact through the KIF5 CBD (Twelvetrees et al., 2010).
Fig. 1. GRIP1 and HAP1 form a complex in
cells and in brain. (A) Schematic of GRIP1
and HAP1 domains. PDZ, PDZ domain; CC,
coiled-coil; A, acidic domain; tail, variable
C-terminal tail. (B) C-terminal sequences of
rat HAP1a and HAP1b. (C–F) COS cells
co-transfected with GFP–GRIP1a and
HA–HAP1a show recruitment of GRIP1 to
HAP1a puncta (C,E). Yellow line, cell
periphery. Scale bars: 10 μm. (D,F) Line scans
through the merged images at the section
highlighted with the white line; peaks
correspond to punctate structures. (G)Western
blot (WB) of immunoprecipitation from COS
cells co-transfected with GFP–GRIP1a and
either HAP1a or HAP1b, immunoprecipitated
with anti-GFP antibody. The interaction is
specific to HAP1a. (H) Western blot of GRIP1
co-immunoprecipitated with HAP1 from rat
brain homogenate.
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When KIF5C is overexpressed in COS cells, it has a tendency to
accumulate in the cell periphery (Dunn et al., 2008). Consistent with
these observations, when overexpressing full-length KIF5C with
HAP1a in HeLa cells or COS cells, we saw good overlap and a
pronounced shift in the localisation of HAP1a clusters away from
the perinuclear region and into the periphery (Fig. 2; Fig. S2).
Similar results were observed with KIF5B, but not KIF5A (Fig. S2),
mirroring our previous data showing that HAP1a interacts poorly
with KIF5A compared to KIF5B and KIF5C in vitro (Twelvetrees
et al., 2010).
In contrast, we saw little overlap between GRIP1 and KIF5C by
immunofluorescence in co-transfectedHeLa cells or COS cells and no
GRIP1 in the cell periphery (Fig. 2; Fig. S2). This observation was
true for all three KIF5 isoforms (Fig. S2). In overexpression studies in
COS cells, wewere also unable to observe an interaction between full-
length KIF5 and GRIP1 by co-immunoprecipitation (data not shown).
Co-expression of HAP1a allows the KIF5C-mediated
redistribution of GRIP1 to the cell periphery
Given the interaction of HAP1a with GRIP1 and KIF5C when
co-expressed in cells, we speculated that the addition of HAP1a
would increase the overlap of GRIP1 with KIF5C. Cells co-
transfected with GRIP1, HAP1a and KIF5C show good overlap of
GRIP1 with KIF5C and redistribution of GRIP1 to the periphery of
the cell (Fig. 3A; Fig. S3E,F). To quantify the redistribution of GRIP1
and HAP1a to the cell periphery by KIF5C, we performed Sholl
analysis on transiently transfected HeLa cells. HAP1a showed a
significant shift to the cell periphery in the presence of KIF5C, which
was not enhanced by the addition of GRIP1 (mean±s.e.m. distance
from the centre 20.21±0.46, 22.66±0.61 and 22.46±0.67 for HAP1a
only, KIF5C+HAP1a or GRIP1+KIF5C+HAP1a, respectively;
Fig. 3A–C). In contrast, GRIP1 localisation was not changed in
the presence of KIF5C alone, but did show a pronounced shift with
the addition of HAP1a (mean±s.e.m. distance from the centre
16.86±0.93, 19.02±1.07, 22.60±0.65 for GRIP1 only, KIF5C+GRIP1
or HAP1a+KIF5C+GRIP1, respectively; see Fig. 3D,E). Both
KIF5B and KIF5C interact well with HAP1a, whereas the
interaction with KIF5A is relatively weak (Twelvetrees et al., 2010).
Consequently, in cells triple transfected with KIF5A, GRIP1 and
HAP1a, only the signal for GRIP1, and HAP1a overlap with one
another and KIF5A itself is not found within the HAP1a and GRIP1
double-positive puncta (Fig. S3A,B), contrary to observations with
KIF5B and KIF5C (Fig. S3C–F).
Biochemical and biophysical studies support the model that the
majority of overexpressed KIF5 in our COS cell system should be in
a folded auto-inhibited conformation due to the lack of similarly
overexpressed adaptor proteins (Coy et al., 1999; Friedman and
Vale, 1999; Stock et al., 1999). We speculated that the GRIP1-
binding site on KIF5 might be masked when KIF5 is autoinhibited
and only exposed in the presence of HAP1a if HAP1a causes release
of KIF5 autoinhibition in a manner similar to JIP1 (also known as
MAPK8IP1) (Blasius et al., 2007), JIP3 (also known as
MAPK8IP3) (Sun et al., 2011) and RanBP2 (Cho et al., 2009),
which bind to the KIF5 CBD. In co-IP studies with KIF5C
fragments from transfected COS cells, we were able to recapitulate
the interaction between GRIP1 and KIF5C (Fig. 3F,G).
Surprisingly, the most efficient GRIP1 interaction occurred with
the KIF5C ‘stalk’ region, rather than the KIF5C ‘tail’ that
incorporates the KIF5 CBD where most adaptors typically bind.
GRIP1 and HAP1a are sufficient to activate KIF5C in in vitro
motility assays
The trafficking of HAP1a to the cell periphery in the presence of
KIF5C is suggestive of HAP1a release of KIF5C autoinhibition.
Additionally, GRIP1 is unable to associate with kinesin and traffic
to the cell periphery without the presence of HAP1a. To test whether
GRIP1 needed HAP1a to activate kinesin, we carried out in vitro
studies to characterise the activation of kinesin in the presence of
these adaptor proteins.
We analysed the activation of KIF5C by total internal reflection
fluorescence microscopy (TIRFM), in a similar manner to that
previously described (Blasius et al., 2007; Sun et al., 2011). COS
cells were mock transfected for the control condition or with either
HA–HAP1a or Myc–GRIP1a. Cell lysates containing individually
expressed adaptor proteinsweremixedwith lysate from cells expressing
Fig. 2. HAP1a but not GRIP1 redistributes to the periphery of HeLa cells
with KIF5C. (A) Singly transfected HeLa cells showing the distribution of
HAP1a, GRIP1 and KIF5C, respectively. Scale bar: 10 µm. (B) KIF5C recruits
HAP1a to the periphery of co-transfected HeLa cells, highlighted by white
arrowhead. An enlarged area shows superposition of HAP1a and KIF5C
puncta. Scale bars: 10 μm (main image) and 2 μm (enlargement). (C) KIF5C is
unable to recruit GRIP1 to the periphery of co-transfected HeLa cells. The
black arrowhead highlights KIF5C-positive GRIP1-negative peripheral puncta.
Scale bars: 10 μm (main image) and 2 μm (enlargement).
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KIF5C labelled with HaloTag TMR ligand (KIF5C–Halo). Mixing
lysates ensured equimolar amounts of KIF5C–Halo in each condition.
Mixed lysates were incubated at room temperature, diluted in assay
buffer and passed into a flow chamber containing immobilised HiLyte
488-labelled microtubules and imaged by TIRFM (Fig. 4A).
We observed a small number of KIF5C–Halo landing (microtubule
binding and release) and motile events in the absence of GRIP1 or
HAP1a (Fig. 4A, Control), likely due to endogenous protein
interactions from the cell lysate or stochastic activation (Fig. 4B).
Adding GRIP1 or HAP1a individually produced more landing
events (total landing events: 304, 490 and 652 for Control, GRIP1
only and HAP1a only, respectively; median landings per micrometre
of 0.56, 0.62 and 1.38; mean±s.e.m. landings per micrometre of 0.78
±0.15, 1.19±0.27, 1.44±0.21; see Fig. 4C) and slightly faster
motility (Fig. S4A). Increased landing events produced more
KIF5C–Halo motile events (n=39, 63, 66 for Control, GRIP1 only
and HAP1a only, respectively), although the proportion of landing
events that result in motility remained constant (Fig. 4D), indicating
stochastic activation of KIF5C once bound to microtubules was
the same in all three conditions. As the concentration of KIF5C is
Fig. 3. GRIP1 can co-complex with KIF5C in the presence of HAP1a through the KIF5 stalk. (A) KIF5C is able to recruit GRIP1 to the periphery of
co-transfected HeLa cells when HAP1a is also present. The boxed area is enlarged on bottom row. Scale bars: 10 μm (main image) and 2 μm (enlargement).
(B) Plot of cumulative distribution of HAP1a signal according to distance from the centre of a cell (HAP1a probability map). Displacement to the right compared to
that in HAP1a only (denoted H) indicates that the HAP1a signal is accumulated further from the centre of the cell. H+K, HAP1a plus KIF5C; H+K+G, HAP1a plus
KIF5C and GRIP1a. Analysis was performed from three independent experiments (n=number of cells; in H, 53; H+K, 43; H+K+G, 39). (C) The distance from the
cell centre at which 95% of the HAP1a signal is found. Analysis was performed from three independent experiments (n=number of cells; in H, 53; H+K, 43;
H+K+G, 39). **P<0.01 (one-way ANOVA test). (D) Plot of the cumulative distribution of GRIP1a signal according to distance from the centre of a cell (GRIP1a
probability map). Displacement to the right compared toGRIP1a only (denotedG) indicates that GRIP1a signal is accumulated further from the centre of the cell. G+K,
GRIP1a plus KIF5C; G+K+H, GRIP1a plus KIF5C and HAP1a. Analysis was performed from three independent experiments (n=number of cells; in G, 31; GK, 29;
GKH, 35). (E) The distance from the cell centre at which 95%of theGRIP1a signal is found. Analysiswasperformed from three independent experiments (n=numberof
cells inG, 31; G+K, 29; G+K+H, 35). **P<0.01; ***P<0.001 (one-way ANOVA test). (F) Schematic representation of KIF5 polypeptide chain showing functional regions
and constructs used. (G) Western blot of co-IP from COS cells showing that Myc–GRIP1 preferentially binds to the stalk region of KIF5.
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the same in all conditions, this may represent partial or transient
unfolding caused by exposure of the MT binding site in either the
head or the tail of KIF5C (Hackney and Stock, 2000, 2008).
However, a striking difference in KIF5C motility was observed
when both GRIP1 and HAP1awere added simultaneously. Not only
were there over three times more landing events compared to the
Control (total=942; median landings per micrometre of 1.72; mean
±s.e.m. landings per micrometre of 2.00±0.3; Fig. 4C), the motility
observed following landing displayed increased speed (Fig. 4B;
Fig. S4A). Characteristic run lengths were: Control, 2.3±0.07;
GRIP1, 3.4±0.08; HAP1a, 2.6±0.2; HAP1a and GRIP1, 2.4±0.03
where ± indicates the standard error of the fit (see also Fig. S4B,C).
Critically, it is only in the condition where both HAP1a and GRIP1
are present that there is a large shift in the proportion of landing events
that result in successful motility (Fig. 4D, median motile percentage:
Control, 10.3%; GRIP1 only, 10.9%; HAP1a only, 10.5%; HAP1a
and GRIP1, 36.4%). Analysis of photobleaching steps for motor–
adaptor complexes immobilised on microtubules after treatment with
the non-hydrolysable ATP analogue AMP-PNP indicated there were
likely two GRIP1 molecules and two HAP1a molecules bound per
motor (most particles with GFP-labelled HAP1a and GRIP1 had
four bleaching steps), although some molecules from the cell
lysate likely represented a dimer of dimers (Fig. 4E,F).
Adaptor protein specificity is thought to underlie the ability of a
relatively small number of motor proteins to transport many unique
cargoes. Consistent with this, substantial evidence suggests both
Fig. 4. Activation of KIF5 motility in vitro requires both HAP1a and GRIP1. (A) Representative motility of KIF5C–Halo in the presence of adaptor proteins
as shown by kymographs and corresponding tracking data. (B) Histograms of the track speed of motile particles for each condition; n=39, 63, 66 and 302
for Control, GRIP1, HAP1a and HAP1a and GRIP1, respectively, from four independent experiments. Histograms are also overlaid with a scaled Gaussian
kernel density plot (solid line). (C) Landing events per micrometre of microtubule; n=14–16 microtubules from four independent experiments. (D) Motile
percentage from the total number of landing events; n=14–16 microtubules from four independent experiments. Box plots are presented as described in
Materials and Methods. (E) Example trace of AMP-PNP-immobilised GFP puncta fluorescence intensity bleaching over time. (F) Photobleaching events per
molecule. Parameters of fitted Gaussians are listed in Tables S1 and S2. (G) Model of KIF5 activation by GRIP1 and HAP1. HAP1a binding is insufficient
to stabilise the open confirmation on its own, but upon co-addition of GRIP1, KIF5 is robustly activated.
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AMPARs (Hoerndli et al., 2013; Hoerndli et al., 2015; Setou et al.,
2002) and GABAARs (Nakajima et al., 2012; Twelvetrees et al.,
2010) are delivered to distinct postsynaptic sites (Gu et al., 2016) by
KIF5 motors. Prior to this work, the role of adaptors GRIP1 and
HAP1 would have fitted neatly into this model. However as
crosstalk between the two now seems necessary to activate KIF5,
this raises a different possibility. GRIP1 is colocalised at inhibitory
synapses both in vitro and in vivo (Burette et al., 1999; Charych
et al., 2006, 2004; Dong et al., 1999a; Kittler et al., 2004a; Li et al.,
2005; Wyszynski et al., 1999), and signalling pathways acting on
the GRIP1 and HAP1 co-complex (both are phospho-proteins;
Kulangara et al., 2007; Rong et al., 2006) could allow crosstalk
between excitatory and inhibitory synapses.
Taken together, our data support a role for adaptor binding to
additional binding elements along the stalk of KIF5 to promote true
motor activation (Fig. 4G). Previous work on one of the first
identified kinesin-1 activators, JIP1, has also isolated an interaction
with the stalk domain (Fu and Holzbaur, 2013). The many contact
points between JIP1 and kinesin may have masked the importance
of the stalk interactions within cells (Blasius et al., 2007; Fu and
Holzbaur, 2013). KLCs were recently shown to have their own
autoinhibition mechanism (Yip et al., 2016) and it is still unclear
how KLC and KIF5 function together in cargo recognition and
motor activation. As HAP1 also binds KLCs (McGuire et al., 2006)
through the conserved KLC-binding motifs (Dodding et al., 2011),
HAP1a and GRIP1 are a complementary system to dissect the
principles of kinesin-1 tetramer activation.
In conclusion, we show that structurally distinct adaptor proteins
can work together to promote full activation of KIF5C in cells. The
co-operative activation mechanism employed by GRIP1 and
HAP1a relies on HAP1a binding to the KIF5 CBD, and a
previously uncharacterised interaction between GRIP1 and the
stalk of KIF5, which further promotes kinesin activation possibly
through stabilising the central hinge.
MATERIALS AND METHODS
Antibodies and constructs
Mouse anti-HAP1 (clone 1/HAP1, cat. no. 611302; 1:250) and mouse anti-
GRIP1 (clone 32/GRIP, cat. no. 611319; 1:200) were both from BD
Biosciences. Fluorescent secondary antibodies were from Invitrogen; HRP-
conjugated secondary antibodies were from Rockland.
All constructs used have been previously described: GFP–GRIP1a
(Hanley and Henley, 2010); Myc–GRIP1a (Kittler et al., 2004a); Myc–
GRIP1–PDZ456 (residues 435–969) (Dong et al., 1999b); HA–HAP1a and
HA–HAP1b (Kittler et al., 2004b; Li et al., 1995); Myc–KIF5A, Myc–
KIF5B and Myc–KIF5C (Twelvetrees et al., 2010); KIF5C-Head–GFP,
Stalk–GFP and Tail–GFP, and KIF5C-Halo (Twelvetrees et al., 2016).
co-IPs using rat brain homogenate
Co-IPs in rat brain homogenate was performed as previously described
(Twelvetrees et al., 2010). All animal experiments were performed according
to approved guidelines (schedule 1 procedures).
COS cell co-IP
COS cells (COS-7 cells from ATCC) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, GIBCO), supplemented with 10% heat
inactivated fetal bovine serum (FBS) and penicillin-streptomycin in a
humidified 5% CO2 atmosphere at 37°C. Cells were transfected using the
Amaxa Nucleofector device (Lonza) following the manufacturer’s protocol.
Transfected cells were harvested at 24 h post transfection. 10 cm dishes of
COS cells were solubilised in 0.5 ml of IP buffer (50 mM Tris-HCl pH 7.5,
0.5% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF in the
presence of antipain, pepstatin and leupeptin) for 10 min at 4°C. Detergent-
solubilised extracts were collected following centrifugation for 10 min at
17,900 g at 4°C, placed in a fresh 1.5 ml microcentrifuge tube and incubated
with 1 µg of antibody for 1 h. Complexes were precipitated with 15 µl of
Protein G–Sepharose beads. Beads were washed three times with IP buffer
then resuspended in 3× protein sample buffer and analysed by SDS-PAGE
and western blotting. 0.5% input was loaded as a comparison.
COS cell immunofluorescence
COS cells were fixed by incubation in −20°C methanol for 10 min.
Coverslips were washed three times with PBS then blocked by incubation
in block solution (PBS with 10% horse serum, 0.5% BSA also containing
0.2% Triton X-100) for 10 min. Primary and secondary antibodies
were diluted in block solution and incubated with coverslips for 1 h at
room temperature, with six brief washes of PBS between incubations.
Coverslips were mounted onto low iron, clear glass slides using ProLong
Gold antifade reagent (Invitrogen) and sealed with nail varnish. Samples
were imaged by confocal laser-scanning microscopy (CLSM) using a
Zeiss LSM 510 META confocal microscope. All images were digitally
captured with LSM software with excitation at 488 nm for GFP and Alexa
Fluor 488, 568 nm for Alexa Fluor 543 and 633 nm for Cy5-conjugated
secondary antibodies. Pinholes were set to 1 Airy unit creating an
optical slice of 0.8 μm. Linescans were prepared in ImageJ/FIJI.
Images for publication were prepared with ImageJ/FIJI and Adobe
Photoshop.
GRIP1a and HAP1a distribution analysis in HeLa cells
HeLa cells (ATCC) were transfected using the Amaxa Nucleofector device
(Lonza) following the manufacturer’s protocol. Cell lines were allowed to
express the exogenous protein for 24 h before immunochemistry using the
same protocol as for COS cells. All cell types were maintained at 37°C in a
humidified atmosphere with 5% CO2. All confocal images were acquired on
a Zeiss LSM700 upright confocal microscope (Carl Zeiss, Welwyn Garden
City, UK) using a 63× oil immersion objective (NA 1.4) with 1024×1024
pixels (101 μm×101 μm) resolution. A suitable threshold was selected for
each channel and Sholl analysis of GRIP1a and HAP1a HA distribution was
performed using a custom-made ImageJ plugin (López-Doménech et al.,
2018, 2016). For every analysis, the cell was isolated, removing signal
coming from other cells around it. Then the centre of the cell was manually
placed and the amount of GRIP1a and HAP1a pixels within shells radiating
out from the soma at 1 μm intervals were automatically quantified. The
cumulative distribution of GRIP1a and HAP1a signal was plotted as a
function of distance from the centre of the cell. The distance where 95% of
the total GFP–GRIP1a and HA–HAP1a signal was calculated for each cell
by interpolation. One average of the GRIP195 and HAP1a95 value was
calculated from all experiments performed (n=total number of cells from
three independent experiments). The experimenter was blind to the
experimental conditions for this distribution analysis.
In vitromotility assays
COS cells were chosen for their low amounts of endogenous kinesin-1
(Cai et al., 2007). FuGENE 6 (Promega) was used to transfect COS cells
with expression plasmids, following the manufacturer’s instructions. All
transfections for this assay were single transfections and cell lysates were
mixed immediately prior to the experiment (see below). Transfected cells
were labelled with HaloTag TMR Ligand (Promega G8252) at 1:10,000
final dilution for 15 min at 37°C, 5% CO2. Cells were washed three times
with fresh medium at 37°C, 5% CO2 for a total of 30 min to remove
unbound ligand. Trypsinised cell pellets were washed three times in PBS
and lysed in 100 µl of lysis buffer (40 mM HEPES/KOH pH 7.4, 1 mM
EDTA, 120 mM NaCl, 0.1% Triton X-100 with protease inhibitor cocktail
and 1 mM ATP) for ten minutes on ice. Lysate was cleared by spinning at
18,000 g at 4°C for 10 min in a benchtop microcentrifuge. Cleared lysate
was kept on ice prior to imaging.
1 µl of KIF5C–Halo lysate was mixed with either 10 µl of control lysate,
10 µl of HAP1a lysate, 10 µl of GRIP1a lysate or 10 µl of a 50:50 mix of
HAP1a and GRIP1a lysates. Mixtures were incubated for 15 min at room
temperature prior to application to the flow chamber (see below). This 10:1
ratio was to ensure saturation of the available kinesin motors with adaptor
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protein. Activation of kinesin was highly variable in the absence of
pre-incubation. Immediately prior to loading into the flow chamber, the
lysatemixwas diluted 1:20 in P12 buffer (12 mMPIPES, 1 mMEGTA, 2 mM
MgCl2), of which 1 µl went on to be imaged (see below). Thus, the
final dilution of labelled kinesin was 2000 fold, and cell lysate as a whole was
200 fold.
Flow chambers (∼10 µl volume) were assembled from cleaned and
silanised (PlusOne Repel-Silane ES, GE Healthcare) coverslips bound on
two sides by double-sided tape and vacuum grease to make a flow channel.
Flow chambers were prepared by flowing in solutions in the following
order: 10 µl of anti β-tubulin (Sigma, TUB2.1) diluted 1:100 in BRB80
(80 mM PIPES, 1 mM MgCl2, 1 mM EGTA pH 6.8) with 5 min
incubation at room temperature (RT); 10 µl of the blocking reagent
50 mg/ml Pluronic F-127 (Sigma) with 5 min at RT; 20 µl of HiLyte 488
labelled microtubules (1:40 ratio of labelled:unlabelled tubulin; labelled
tubulin from Cytoskeleton, Inc.; unlabelled tubulin purified in-house from
bovine brain) diluted in TBRB80 (BRB80+20 µM Taxol) with 5 min at
RT; 20 µl of P12T (P12+20 µM Taxol) to wash out unbound microtubules.
Into this prepared chamber was flowed 1 µl of prepared cell lysate diluted
in 10 µl of assay buffer (P12T+0.3 mg/ml BSA, 0.3 mg/ml casein, 10 mM
DTT, 10 mM MgATP, 15 mg/ml glucose, 0.5 μg/ml glucose oxidase and
470 U/ml catalase).
Imaging was performed with Ultraview Vox (PerkinElmer) system with
100× apochromat 1.49 NA oil immersion objective (Nikon). Chambers were
imaged at 5 frames per second.
In vitromotility analysis
Kinesin particle tracks were analysed using the TrackMate plugin for FIJI/
ImageJ (Schindelin et al., 2012). Particle sizewas∼0.8 µm or 5 pixels (pixel
size=158 nm). Tracks were fitted with sub-pixel resolution. Particles within
the TIRF field, but not in close enough proximity to bind to the microtubule,
were automatically excluded from analysis.
Track data generated by TrackMate was subsequently analysed in
R softwarewith the dplyr package to summarise data and ggplot2 for plotting.
Given the unidirectional nature of kinesin tracks on microtubules, track speed
was measured as the whole track displacement relative to the track duration.
To be included as a ‘landing event’, the particle had to be bound for 0.4 s (two
frames), related to the frame rate of 5 fps. To get accurate analysis of track
speed, particles that moved less than 0.6 µm were excluded.
Summary data is represented as box and whisker plots where the heavy
horizontal line represents the median, box upper and lower limits
represent 25th and 75th percentiles and whiskers extend to the closest
value within 1.5× the inter-quartile range. The mean is represented by a
diamond. Significant difference within data sets was initially tested using the
Kruskal–Wallis rank sum test and, if P<0.05, was further investigated using
pairwise Mann–Whitney–Wilcoxon tests with Bonferroni correction. These
tests make no assumptions about the data distribution; values of P<0.05 are
reported.
Characteristic run length was determined using methods as previously
described (Thorn et al., 2000) using the nonlinear least-squares function
(nls) in R software. Cumulative frequency distributions (Fig. S4) were
compared using the Kolmogorov–Smirnov test.
Photobleaching event analysis was carried out on puncta immobilised on
microtubules with 15 mM AMP-PNP in the assay buffer instead of ATP.
Briefly, using ImageJ a 6×6 region of interest (ROI) was centred on spots
bound to microtubules based on the maximum projection of the image stack,
together with an adjacent 6×6 ROI to measure local background and account
for uneven illumination. Background was subtracted from the integrated
density of each spot at every time point and plotted. Bleaching events
corresponding to clear steps in fluorescence intensity were counted for each
spot. Population analysis on photobleaching events was performed using
model-based clustering with the mixtools package in R software. Given that
the number of photobleaching events for any complex must be an integer,
fitting was performed specifying that the number of distributions in the data
was three, with the mean (μ) of each distribution constrained to 2, 4 and 8
photobleaching events, respectively. The standard deviation (σ) and
amplitude (λ) for the resulting distributions is shown in Table S1 and
normal distributions plotted in Fig. 4F.
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